Stock Events

Stock Events

Search...

Prelude Therapeutics (PRLD) Q3 2023 Earnings

1NovConfirmed

Q4 2022

Q1 2023

Q2 2023

Q3 2023

-0.68

-0.6

-0.53

-0.45

Details

Expected EPS

-0.58

Actual EPS

-0.45

Surprise EPS

0.13

Surprise Percent

+22.41%

Description

Prelude Therapeutics (PRLD) has reported earnings of -0.45 per share for Q3 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.